oxonic acid has been researched along with Coronary Vasospasm in 2 studies
Oxonic Acid: Antagonist of urate oxidase.
Coronary Vasospasm: Spasm of the large- or medium-sized coronary arteries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 58-year-old male with advanced gastric cancer underwent a total gastrectomy after neoadjuvant chemotherapy with paclitaxel and cisplatin." | 1.34 | A case of suspected vasospastic angina related to S-1 administration. ( Hoshi, Y; Kameda, K; Munakata, M; Muto, O; Sakata, Y; Shitara, K, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwakman, JJM | 1 |
| Baars, A | 1 |
| van Zweeden, AA | 1 |
| de Mol, P | 1 |
| Koopman, M | 1 |
| Kok, WEM | 1 |
| Punt, CJA | 1 |
| Shitara, K | 1 |
| Kameda, K | 1 |
| Hoshi, Y | 1 |
| Munakata, M | 1 |
| Muto, O | 1 |
| Sakata, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Feasibility of Switching Fluoropyrimidine Due to Cardiotoxicity in Patients With Solid Tumors: A Retrospective, International and Non-interventional Study[NCT04260269] | 200 participants (Anticipated) | Observational | 2018-06-01 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for oxonic acid and Coronary Vasospasm
| Article | Year |
|---|---|
Case series of patients treated with the oral fluoropyrimidine S-1 after capecitabine-induced coronary artery vasospasm.
Topics: Administration, Oral; Aged; Breast Neoplasms; Capecitabine; Cardiotoxicity; Colorectal Neoplasms; Co | 2017 |
A case of suspected vasospastic angina related to S-1 administration.
Topics: Angina Pectoris, Variant; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Coronary Vasospas | 2007 |